Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 16, 2024 4:28pm
72 Views
Post# 35829948

RE:RE:Interest rates

RE:RE:Interest rates"Also all these interested parties and never a single deal..."

All CZO has currently is a pilot-scale 10L PBX facility. 10L isn't much. It is pre-commercial. It is pilot-scale. 

On November 7, 2022, in a news release, CZO stated:


"This next phase of scale up will allow us to work with commercial partners in nutraceuticals and pharmaceuticals to formulate, test, and commercialize novel products and formulations, including novel functional foods and beverages, novel drugs and various forms of delivery systems,” said Gilles Gagnon, M.Sc., MBA, President and CEO." 

The 5X PGX scale-up facility was to be completed last month with commissioning by the end this quarter. At the same time, with Natex, they are building a 10X scale-up to 100L. The 100L facility is expected to be built by September of this year with commissioning by the end of the year. As the Nov. 23, 2023 news release says, "
NATEX are experts at design and construction of full-scale commercial plants based on the 100L scale."

The 5X scale-up will provide limited commercial PGX volumes but the 10X scale-up to 100L expected to be commissioned by year-end positions a potential partner for mass industrialization. The 100L facility would appear to best support a licening deal. 


 
<< Previous
Bullboard Posts
Next >>